Sysa-Jedrzejowska A - Search Results

1

Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters.

Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, Zabek J, Kontny E, McCauliffe D, Wozniacka A. Bogaczewicz J, et al. Lupus. 2012 Apr;21(5):477-84. doi: 10.1177/0961203311427549. Epub 2011 Nov 7. Lupus. 2012. PMID: 22065093

2

[Prevalence of autoantibodies directed against 1,25(OH)2D3 in patients with systemic lupus erythematosus].

Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, Zabek J, Kontny E, Wozniacka A. Bogaczewicz J, et al. Pol Merkur Lekarski. 2010 Feb;28(164):103-7. Pol Merkur Lekarski. 2010. PMID: 20369736 Polish.

3

Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.

Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T. Robak E, et al. Lupus. 2002;11(6):348-55. doi: 10.1191/0961203302lu199oa. Lupus. 2002. PMID: 12139372

4

Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients.

Wozniacka A, Lesiak A, Narbutt J, McCauliffe DP, Sysa-Jedrzejowska A. Wozniacka A, et al. Lupus. 2006;15(5):268-75. doi: 10.1191/0961203306lu2299oa. Lupus. 2006. PMID: 16761500 Clinical Trial.

5

The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters.

Wozniacka A, Cygankiewicz I, Chudzik M, Sysa-Jedrzejowska A, Wranicz JK. Wozniacka A, et al. Lupus. 2006;15(8):521-5. doi: 10.1191/0961203306lu2345oa. Lupus. 2006. PMID: 16942005

6

Chloroquine treatment reduces the number of cutaneous HLA-DR+ and CD1a+ cells in patients with systemic lupus erythematosus.

Wozniacka A, Lesiak A, Narbutt J, Kobos J, Pavel S, Sysa-Jedrzejowska A. Wozniacka A, et al. Lupus. 2007;16(2):89-94. doi: 10.1177/0961203306075384. Lupus. 2007. PMID: 17402364

7

Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.

Lesiak A, Narbutt J, Sysa-Jedrzejowska A, Lukamowicz J, McCauliffe DP, Wózniacka A. Lesiak A, et al. Lupus. 2010 May;19(6):683-8. doi: 10.1177/0961203309356455. Epub 2010 Jan 11. Lupus. 2010. PMID: 20064914

8

Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population--a preliminary report.

Bogaczewicz A, Sobow T, Bogaczewicz J, Kaleta B, Sysa-Jedrzejowska A, Robak E, Lukaszkiewicz J, Dariusz S, Wozniacka A. Bogaczewicz A, et al. Lupus. 2013 Dec;22(14):1504-8. doi: 10.1177/0961203313511553. Lupus. 2013. PMID: 24243911

9

Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus--a case report.

Bogaczewicz J, Sobów T, Bogaczewicz A, Robak E, Bienkowski P, Sysa-Jedrzejowska A, Wozniacka A. Bogaczewicz J, et al. Lupus. 2014 Feb;23(2):188-93. doi: 10.1177/0961203313513818. Epub 2013 Dec 2. Lupus. 2014. PMID: 24297641

10

Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.

Robak E, Smolewski P, Wozniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T. Robak E, et al. Eur Cytokine Netw. 2004 Jul-Sep;15(3):222-30. Eur Cytokine Netw. 2004. PMID: 15542447 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters